Home › Funds › BANNERMAN WEALTH MANAGEMENT GROUP, LLC › ALNY
BANNERMAN WEALTH MANAGEMENT GROUP, LLC position in ALNY
ALNYLAM PHARMACEUTICALS INC · Health Care
BANNERMAN WEALTH MANAGEMENT GROUP, LLC reported holding 1,850 shares of ALNY (ALNYLAM PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$456K, representing 0.27% of its reported portfolio and ranking #25 among its reported holdings. BANNERMAN WEALTH MANAGEMENT GROUP, LLC has disclosed ALNY holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
Last updated: 2026-10-09 · Source: SEC EDGAR Form 13F-HR
How BANNERMAN WEALTH MANAGEMENT GROUP, LLC's ALNY position evolved
BANNERMAN WEALTH MANAGEMENT GROUP, LLC first disclosed a stake in ALNY in Q4 2024 at 1,391 shares (US$327K). The position peaked in Q3 2025 at 2,047 shares, worth US$933K. Across 8 filings, BANNERMAN WEALTH MANAGEMENT GROUP, LLC increased the stake 1 time(s), trimmed it 6 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,850 shares valued at US$456K — a reduction of -33 shares quarter over quarter.. Notable position changes include a 96% increase in Q1 2025 (shares rose 20% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 1.39K | $327.32K | New |
| Q1 2025 | 2.73K | $736.88K | Add |
| Q2 2025 | 2.16K | $705.66K | Reduce |
| Q3 2025 | 2.05K | $933.43K | Reduce |
| Q4 2025 | 1.95K | $774.23K | Reduce |
| Q1 2026 | 1.92K | $633.95K | Reduce |
| Q2 2026 | 1.88K | $566.84K | Reduce |
| Q3 2026 | 1.85K | $456.47K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ALNY and 13F data
ALNY (ALNYLAM PHARMACEUTICALS INC) is a Health Care company. 36 other funds we track also report a position in ALNY — the largest reported positions include T. Rowe Price Investment Management, Inc. (US$1.70B), Baillie Gifford & Co (US$734.5M), Orbis Allan Gray Ltd (US$598.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ALNY
- T. Rowe Price Investment Management, Inc. 5.64M sh · $1.70B · Q2 2026
- Baillie Gifford & Co 2.44M sh · $734.48M · Q2 2026
- Orbis Allan Gray Ltd 1.99M sh · $598.27M · Q2 2026
- Two Sigma Investments 1.88M sh · $564.71M · Q2 2026
- AMERICAN CENTURY COMPANIES INC 1.85M sh · $558.10M · Q2 2026
- TWO SIGMA ADVISERS, LP 1.13M sh · $450.36M · Q4 2025
- Deep Track Capital, LP 825.00K sh · $248.35M · Q2 2026
- Qube Research & Technologies Ltd 798.72K sh · $240.44M · Q2 2026
- LOS ANGELES CAPITAL MANAGEMENT LLC 729.63K sh · $219.64M · Q2 2026
- LOOMIS SAYLES & CO L P 580.19K sh · $174.65M · Q2 2026
More on BANNERMAN WEALTH MANAGEMENT GROUP, LLC
FAQ
How long has BANNERMAN WEALTH MANAGEMENT GROUP, LLC held ALNY?
BANNERMAN WEALTH MANAGEMENT GROUP, LLC has disclosed ALNY holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
What is BANNERMAN WEALTH MANAGEMENT GROUP, LLC's current position in ALNY?
As of Q3 2026, BANNERMAN WEALTH MANAGEMENT GROUP, LLC holds 1.85K shares of ALNY (ALNYLAM PHARMACEUTICALS INC), valued at $456.47K, representing 0.27% of its reported portfolio and ranking #25.
Has BANNERMAN WEALTH MANAGEMENT GROUP, LLC been buying or selling ALNY?
In the latest 13F filing (Q3 2026), BANNERMAN WEALTH MANAGEMENT GROUP, LLC reduced its position in ALNY. The position peaked in Q3 2025 at 2.05K shares.
Which other funds hold ALNY?
Other major institutional holders of ALNY include T. Rowe Price Investment Management, Inc., Baillie Gifford & Co, Orbis Allan Gray Ltd, among 36 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.